Reference | Patients | Follow up (months) | Particles | Dose (GyE) | LC-5 (%) | SV-5 (%) | Complication rate (%) |
---|---|---|---|---|---|---|---|
Castroet al 38 | 27 | 4–191 | Helium, | 60–80 | 78 | 83 | 41 (77–86) |
(median 51) | neon | (median 66) | 20 (87–92) | ||||
Munzenrider et al 46 | 81 | 2–187 | Proton | 62.8–77.4 | 91 | 94 | 13 (auditory) |
(median 37) | (median 68.5) | 12 (endocrine) | |||||
10 (brain) | |||||||
6 (visual) |
LC-5 = local control rate at 5 y; SV-5 = survival rate at 5 y; GyE = Gray equivalent.